Pfizer’s strategy chief Andrew Baum steps down; Helus Pharma swaps out CEO after two months

→ Ex-Citi analyst Andrew Baum has left his role as chief strategy and innovation officer at Pfizer, but he will be a senior strategic advisor to CEO Albert Bourla. BMO Capital Markets broke the news ...